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Background: Olig1 and Olig2, encoding closely related basic helix-loop-helix transcription factors, were originally
identified in screens for glial-specific genes. Olig1 and Olig2 are both expressed in restricted parts of the
neuroepithelium of the embryonic spinal cord and telencephalon and subsequently in oligodendrocyte lineage
cells throughout life. In the spinal cord, Olig2 plays a crucial role in the development of oligodendrocytes and
motor neurons, and both cell types are lost from Olig2 null mutant mice. The role of Olig1 has been more cryptic. It
was initially reported that Olig1 null mice (with a Cre-Pgk-Neo cassette at the Olig1 locus) have a mild developmental
phenotype characterized by a slight delay in oligodendrocyte differentiation. However, a subsequent study of the
same line following removal of Pgk-Neo (leaving Olig1-Cre) found severe disruption of oligodendrocyte production,
myelination failure and early postnatal lethality. A plausible explanation was proposed, that the highly expressed
Pgk-Neo cassette in the original line might have up-regulated the neighbouring Olig2 gene, compensating for loss
of Olig1. However, this was not tested, so the importance of Olig1 for oligodendrocyte development has remained
unclear.
Results: We generated two independent lines of Olig1 null mice. Both lines had a mild phenotype featuring slightly
delayed oligodendrocyte differentiation and maturation but no long-term effect. In addition, we found that Olig2
transcripts were not up-regulated in our Olig1 null mice.
Conclusions: Our findings support the original conclusion that Olig1 plays a minor and non-essential role in
oligodendrocyte development and have implications for the interpretation of studies based on Olig1 deficient mice
(and perhaps Olig1-Cre mice) from different sources.
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Oligodendrocyte lineage genes Olig1 and Olig2 encode basic
helix-loop-helix (bHLH) transcription factors. Olig2 is a
master regulator of oligodendrocyte (OL) lineage develop-
ment [1-3]. Olig2 is also required for generation of some
neurons, notably spinal motor neurons (MNs) [1-3]. MNs
are generated from neural stem/progenitor cells in a spe-
cialized region of the ventral ventricular zone (VZ) of the
spinal cord known as pMN. Around embryonic day 12
(E12) in mice, the same group of progenitors stops produ-
cing MNs and switches to production of OL precursors
(OPs), which proliferate and migrate away from the VZ in* Correspondence: w.richardson@ucl.ac.uk
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reproduction in any medium, provided the orall directions before associating with axons and differentiat-
ing into myelin-forming OLs (reviewed in reference [4]).
Olig1 and Olig2 (referred to here as Oligs) are involved at
multiple stages of this developmental sequence. Olig2 is
also required for specifying oligodendrocytes and some
types of neurons in the brain – some ventrally-derived in-
terneurons and cholinergic projection neurons in the fore-
brain, for example [5].
Olig1 can compensate for Olig2 in some regions includ-
ing the hindbrain and parts of the forebrain, because OPs
still form there in Olig2 null mice but not in Olig1/Olig2
double nulls [1,3]. Olig1 also plays a later role in the differ-
entiation of OPs into myelinating OLs, although there is
disagreement about whether there is an absolute require-
ment for Olig1 during normal development [1,6]. The
original Olig1 null allele, made by inserting a Cre-frt-Pgk-
Neo-frt cassette into the mouse Olig1 locus [1] caused al Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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term myelin deficit. However, a subsequent study by Xin
et al. [6], who crossed the original line with FLP-expressing
mice to remove the Pgk-Neo selection cassette (leaving be-
hind Olig1-Cre), found a severe myelination defect leading
to early postnatal lethality. Apart from this contested role
in OL lineage development, Olig1 is known to be required
for remyelination of experimentally-induced demyelinated
lesions in the mouse spinal cord [7].
Given the central role of the Oligs in OL lineage develop-
ment, it is important to try to settle the controversy over
the developmental requirement for Olig1. This might have
added significance because the Olig1 null locus [1,6] con-
tains an expressed Cre cassette under Olig1 transcriptional
control and these Olig1(+/Cre) mice are being used to
delete floxed genes specifically in OL lineage cells. For ex-
ample, conditional deletion of Dicer1 (flox/flox) using Olig1
(+/Cre) [6] caused severe impairment of myelination and
death around P21 [8], whereas analogous experiments
using Olig2(+/Cre) or Cnp(+/Cre) resulted in only slightly
delayed myelination with full recovery by P60 [9]. In an-
other example, constitutively activating the Wnt signaling
pathway by conditional deletion of exon 3 of β-catenin [10]
using Olig1(+/Cre) completely prevented OL lineage speci-
fication, judging by the complete absence of OP markers
such as Pdgfra [11], whereas similar experiments using
Olig2(+/Cre) did not affect OP specification but only their
subsequent differentiation into OLs [12]. While there might
be a simple explanation for these differences, such as earlier
or more complete recombination by Olig1(+/Cre) than by
Olig2(+/Cre), the possibility remains that the Olig1 null al-
lele generated by Xin et al. [6] might carry some additional,
unidentified defect that can amplify the phenotype of other
deleterious mutations.
To attempt to throw some light on these matters
we undertook a study of two independent Olig1 null
lines generated in our own laboratory. We found that
loss of Olig1 causes a transient delay in OL develop-
ment and myelination. We quantified Olig2 mRNA in
our Olig1 mutant mice and found no increase relative
to wild type controls. The mild phenotype we observe
is therefore likely to be a genuine consequence of




Mice were maintained on a 12 hour light–dark cycle.
For timed mating, male and female mice were caged
together overnight (from ~6 pm) and 12 noon the
following day was designated embryonic day 0.5 (E0.5).
All mouse work was approved by the Home Office of
the UK Government, and conformed to the Animals
(Scientific Procedures) Act 1986. New Olig1 null lines,Olig1(−/−) and Olig (−/−), Olig2(Tg) were generated as
described previously [13] (also see Results).Embryonic Stem (ES) cell targeting
We generated a new Olig1(−/−) line by ES cell targeting.
Briefly, Olig1 targeting vector (see Results) was linear-
ized and electroporated into R1 ES cells (129 back-
ground) [14]. After 10 days’ selection in 150 μg/ml G418
(Invitrogen), 200 colonies were picked and expanded in
96-well plates. Targeted ES clones were identified by
Southern blotting using a 700 bp NcoI—EcoRI fragment
as probe (Figure 1B). Positive ES clones were confirmed
by Southern blotting using a 200 bp PstI—NcoI probe
(Figure 1C). Five correctly targeted ES cell clones were
expanded for karyotyping; two clones with normal
karyotype were used for C57/B6 blastocyst injection to
produce chimeric mice. Male chimeras were bred to
C57/B6 females to produce Olig1 heterozygotes.Tissue preparation and histochemistry
Embryonic and postnatal spinal cords or brains
were immersion-fixed in 4% (w/v) paraformaldehyde in
phosphate-buffered saline (PBS) overnight at 4°C. The
tissue was cryo-protected overnight at 4°C in 20% (w/v)
sucrose in PBS. Tissue was embedded in OCT com-
pound (Tissue-Tek), rapidly frozen on dry ice/isopentane
and stored at −80°C. Tissue was cryo-sectioned (nominal
thickness 30 μm) in a Bright cryotome and sections col-
lected on Superfrost Plus slides. Sections were treated
with blocking solution [10% (v/v) fetal calf serum in
0.1% (v/v) Triton X-100 in PBS] at 20-25°C for one hour
before immuno-labeling. Primary antibodies were anti-
Sox10 (guinea pig, 1:4,000 dilution; a gift from M.
Wegner, University of Erlangen) and anti-Olig1 (rabbit,
1:4,000 dilution; a gift from Charles Stiles, Dana Farber
Cancer Institute, Harvard Medical School). Secondary
antibodies were Alexa Fluor 488 conjugated goat anti-
rabbit and Cy3-conjugated goat anti-guinea pig IgG
(Chemicon, 1:500 dilution). Sections were counter-
stained with Hoechst 33258 dye (Sigma, 1000-fold dilu-
tion), for 10 minutes at 20-25°C after the secondary
antibody and mounted under coverslips in fluorescence
mounting medium (Dako).
Our fluorescence in situ hybridization procedure has
been described before; detailed protocols are available at
http://www.ucl.ac.uk/~ucbzwdr/Richardson.htm. Briefly,
digoxigenin (DIG)-labelled RNA probes were transcribed
in vitro from cloned cDNAs of Mbp or Plp. After
hybridization, the DIG signal was detected using horse-
radish peroxidase (HRP)-conjugated anti-DIG (Roche)
followed by developing in fluorescein-tyramide reagent
(NENTM Life Science Products, Boston).
Figure 1 Generation of Olig1 null mouse lines. (A) The Olig1 ORF was replaced by Notch1 intracellular domain (NICD) by homologous
recombination in ES cells followed by blastocyst injection to generate Olig1(−/−) mice. A Pgk-Neo cassette, flanked by loxP sites, was inserted just
upstream of NICD. Arrows indicate the 5’-3’ directions of each coding region. (B) Southern blot of NcoI-digested genomic DNA using a 700 bp 5’
probe revealed a 4.1 kb band in wild type mice. An additional 4.9 kb band was identified in heterozygous mice. (C) Southern blots of
NcoI/AscI-digested genomic DNA using a 200 bp 3’ probe revealed a 5.3 kb band in wild type mice. An additional 5 kb band was identified in
heterozygous mice due to the introduction of a new AscI site in the targeting vector as part of the cloning procedure. (D) Olig2 expression was
not up-regulated in Olig1(−/−) mice. Quantitative PCR using cDNA templates acquired from E13.5 and E18.5 forebrain tissues revealed that Olig1
heterozygotes and homozygous knockout mice expressed similar amounts of Olig2 mRNA. (E) As an alternative approach to generating Olig1 null
mice, Olig2 PAC transgenic mice (generated by pronuclear injection; [13]) were crossed to Olig1/2 double KO mice to rescue Olig2 and produce
[Olig(-/-), Olig2(Tg)] mice, which phenocopy Olig1(−/−). Arrows show the direction of transcription.
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Quantitative PCR (qPCR) was performed using forebrain
and spinal cord tissue collected from Olig1 null mice
and control littermates that carried either one or two en-
dogenous copies of Olig1 at embryonic day 13.5 (E13.5)
and/or E18.5. The tissue was homogenized in the pres-
ence of Trizol reagent (Invitrogen), and total RNA was
purified and used for cDNA synthesis following the
manufacturer’s instructions. Oligonucleotides 5′ att gta
caa aac ggc cac aa 3′ and 5′ agt gct ctg cgt ctc gtc ta 3′
were used for Olig2 cDNA amplification. Oligonucleo-
tides 5′ aca act ttg gca ttg tgg aa 3′ and 5′ gat gca ggg
atg atg ttc tg 3′ were used to amplify Gapdh as an in-
ternal control. qPCR values were calculated using the
relative standard curve method. At least three embryos
of each genotype were analyzed at each age.
Mouse embryonic fibroblast (MEF) culture and Western
blotting
Mouse embryos (E13.5-E15.5) were placed in PBS (with-
out Mg or Ca) and the head, vertebral column, dorsal
root ganglia, and inner organs were removed. The
remaining tissue was digested in 0.25% (w/v) trypsin,
finely minced with a razor blade and incubated at 37°C
for 15 minutes to make a single-cell suspension. Cells
were then plated in 35 mm dishes coated with 0.1%
(w/v) gelatin and grown at 37°C in 5% (v/v) CO2 in MEF
medium (DMEM-Glutamax, 10% FBS, 1:100 MEM non-
essential amino acids and 1:1000 2-mercaptoethanol,Invitrogen). A plasmid encoding Cre under the control
of the PGK promoter (pPGKcreSV40) was used for
transfection with Fugene 6 (Promega). Proteins from
transfected MEFs and mouse spinal cord tissue were sepa-
rated by SDS-PAGE and transferred to polyvinylidene
difluoride membranes. Rabbit anti-Myc antibody was pur-
chased from Abcam and used at a 1:10,000 dilution. Pro-
tein bands were visualized by chemi-luminescence (ECL
reagent; GE Healthcare).
Results
Generation of new Olig1 null mouse lines
To try to resolve the discrepancy between the reported
phenotypes of two different Olig1 null mouse lines [1,6]
we generated two new Olig1 null strains, using different
approaches. For one, we replaced the Olig1 open reading
frame (ORF) with a DNA fragment including an inverted
phosphoglycerate kinase promoter -neomycin resistance
cassette (Pgk-Neo) flanked by loxP sites in mouse embry-
onic stem (ES) cells, line R1 [14] (Figure 1A). We refer
to this line as Olig1(−/−). For purposes unrelated to the
work described here, the modified locus also included a
Myc-tagged Notch intracellular domain (NICD) coding
sequence downstream of the floxed Pgk-Neo cassette; in
the absence of Cre recombinase this NICD cassette is
not expressed (Additional file 1: Figure S1) and is
phenotypically neutral. Targeted clones were identified
by Southern blot analysis of genomic DNA using a
700 bp NcoI–EcoRI fragment as a 5′ probe (Figure 1B).
Figure 2 No OL differentiation in E17.5 Olig1 null spinal cord.
Fluorescence in situ hybridization for myelin basic protein (Mbp)
(A,C,E,G) or proteolipid protein (Plp) (B,D,F,H) gene transcripts was
performed on sections of E17.5 mouse spinal cords. No Mbp- or
Plp-positive cells were detected in the circumferential white matter
of Olig1(−/−) or Olig(-/-),Olig2(Tg) cords (C,D and G,H respectively)
compared to cognate Olig1(+/−) controls (A,B and E,F). Scale
bar: 80 μm.
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NcoI fragment as a 3′ probe (Figure 1C). One karyotypi-
cally normal ES cell line was selected for blastocyst
injection and germline transmission.
Our second Olig1 KO was generated by crossing Olig1/
Olig2 double-null mice [3] with a phage artificial chromo-
some (PAC) transgenic line that contains a single copy
of mouse Olig2 [13] (Figure 1E). We refer to this line as
Olig (−/−), Olig2(Tg). We confirmed that this line does not
express Olig1 protein (Additional file 2: Figure S2).
Lack of compensatory up-regulation of Olig2 in Olig1-null
mice
The Olig1 and Olig2 genes are located about 40 kb apart on
mouse chromosome 16 and there is a large degree of over-
lap in their expression patterns in vivo [15]. Xin et al. [6]
suggested that the Pgk-Neo cassette introduced by Lu et al.
[1] to disrupt the Olig1 ORF might have exerted a cis-
activating effect on the neighbouring Olig2 locus, resulting
in over-expression of Olig2 which compensated for loss of
Olig1. Since our own Olig1(−/−) mice also contain a Pgk-
Neo cassette at the Olig1 locus (but in the opposite orienta-
tion to the mice described in reference 1), we compared
Olig2 mRNA levels in our Olig1(−/−) mice and Olig1(+/−)
controls. We collected forebrain tissue at two embryonic
stages (E13.5 and E18.5) and quantified Olig2 transcripts by
PCR, using total cellular RNA as substrate. We could not
detect a significant difference in the brain or spinal cord be-
tween Olig1(−/−) and Olig1(+/−), indicating that Olig2 was
not mis-regulated by the Pgk-Neo cassette at the Olig1 locus
in our mice (Figure 1D and Additional file 3: Figure S3).
Note that although two Pgk-Neo cassettes are present
at the disrupted Olig1/Olig2 locus in our Olig(−/−),
Olig2 (Tg) mice (Figure 1E) they are almost certainly
physically remote from the randomly-integrated Olig2
PAC transgene and therefore are not expected to impose
cis-regulation on Olig2.
Oligodendrocyte precursors are specified normally in
Olig1 null CNS
We analyzed the expression of both platelet-derived
growth factor receptor-alpha (Pdgfra), a marker of OPs,
and Sox10, which marks all stages of the OL lineage, by
immunofluorescence microscopy of E15.5 spinal cord and
P2 forebrain sections. Neither Pdgfra nor Sox10 expression
were noticeably altered in our two Olig1 null lines, relative
to Olig1(+/−) controls (not shown). This is as expected,
given that Olig1 protein does not appear until after OP
specification [16], and is consistent with the phenotypes of
the two previously-described Olig1 null lines [1,6].
OL differentiation is delayed in Olig1 null spinal cord
To investigate OL differentiation in our two new Olig1
null lines, we visualized mRNAs encoding mature OLmarkers myelin basic protein (MBP) and myelin proteo-
lipid protein (PLP) by in situ hybridization. At E17.5,
Mbp and Plp transcripts were absent from spinal cord in
both Olig1 null lines, in contrast to littermate controls
that carried one good copy of endogenous Olig1
(Figure 2). At E18.5, Mbp and Plp transcripts were
present but in lower numbers of cells relative to Olig1
0heterozygotes (Figure 3); by postnatal day 3 (P3), there
were normal numbers of Mbp and Plp-positive cells in
the Olig1 null spinal cord (Figure 4). These results indi-
cate that Olig1 is involved in, but is not critically import-
ant for OL differentiation in the developing spinal cord,
consistent with the original study by Lu et al. [1].
Figure 3 Reduced OL numbers in E18.5 in Olig1 null embryos. The levels of Mbp (C,G) and Plp (D,H) expression were decreased in Olig1 null
spinal cords compared to corresponding controls (A,E and B,F respectively). Differentiating OLs were quantified based on Mbp and Plp
expression (I). Three sections per embryo (n = 3) were counted and the data presented as mean ± s.e.m. p values (p < 0.05) were calculated by
Student’s t-test. Scale bar: 80 μm.
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until after birth [17]. On forebrain sections, few Mbp
and/or Plp positive cells were detectable by fluorescence
in situ hybridization at P4 (not shown). At P7, both
Olig1 null lines appeared to have normal numbers of
Mbp and Plp positive cells in both the corpus callosum
and cortex compared to control mice (Additional file 4:
Figure S4).
Discussion
We generated two new Olig1 null mouse lines by different
routes -one by homologous recombination in ES cells
followed by blastocyst injection, and the other by transgenic
rescue of a previously generated Olig1/Olig2 double-null
line [3] by pronuclear injection of an Olig2 PAC. Neither of
the Olig1 null lines showed any evidence of prenatal lethal-
ity and both lines lived and reproduced normally. There
was a transient delay in the production of differentiated
OLs in the spinal cords of both our Olig1 null lines, as ori-
ginally reported by Lu et al. [1] but in contrast to Xin et al.
[6], who reported a severe myelination block that resulted
in death around the third postnatal week. Xin et al. [6] put
the discrepancy down to the fact that the original Olig1 null
allele retained a Pgk-Neo cassette, speculating that the pres-
ence of this highly-transcribed element might have caused
compensatory up-regulation of the neighbouring Olig2gene. Xin et al. [6] removed the Pgk-Neo cassette (which
was flanked by frt sites) by crossing the original Lu et al. [1]
line with FLP-expressing mice. However, they did not quan-
tify Olig2 expression in either of the Olig1 mutants.
A cis-acting regulatory effect of Pgk-Neo has been im-
plied in previous studies. For example, the initially re-
ported lethal phenotype of a germ line Surf1 deletion
[18] was later attributed to the effect of Pgk-Neo on ex-
pression of unidentified genes near the Surf1 locus, after
a second Surf1 knockout line lacking the Pgk-Neo cas-
sette was found to be unusually long-lived [19]. Another
example is the germ line knockout of the zinc finger
transcription factor Zfp191, which was initially reported
to be embryonic-lethal [20]. Subsequently, an independ-
ent line was found to survive after birth, developing a se-
vere dysmyelinating phenotype and dying around P25
[21]. One potential explanation for the difference was
that the embryonic-lethal allele contained an expressed
Neo selection cassette. We tested the hypothesis that the
mild phenotype of our Olig1(−/−) mice might have been
due to compensatory up-regulation of the adjacent Olig2
gene by Pgk-Neo, but found no evidence for this. Our
data are consistent with a previous study by Samanta
et al. [22] who found no evidence for up-regulation of
Olig2 when they used the Olig1(+/Cre) line of Lu et al.
[1] (which also contains Pgk-Neo) for conditional
Figure 4 OL numbers recover by P3. At P3, the numbers of Mbp-and Plp-expressing cells in Olig1 null spinal cords (C,D and G,H) were
indistinguishable from controls (A,B and E,F respectively). Differentiating OLs were quantified based on Mbp and Plp expression (I). Three
sections per mouse (n = 3) were counted and the data displayed as mean ± s.e.m. p values (p < 0.05) were calculated by Student’s t-test. Scale
bar: 100 μm.
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(BMPR1a). Taken together, the data indicate that the
presence or absence of Pgk-Neo cannot easily explain the
dramatically different developmental phenotypes of dif-
ferent Olig1 null mice.
Different phenotypic outcomes for the same gene dele-
tion can sometimes result from differences in the genetic
backgrounds of the mice. For example, the effect of knock-
ing out Nogo-A, a membrane protein of the adult myelin
sheath and an inhibitor of neurite growth and axon regen-
eration, has a much larger effect on neurite regeneration
ability in the 129X1/SvJ background than in the C57BL/6 J
(C57) background [23]. Our Olig1(−/−) line was generated
using R1 ES cells (129 background; reference [14]). Homo-
zygous nulls were maintained in a 129/C57 mixed back-
ground for many (>10) generations with no sign of
lethality. They are now maintained on a 129/C57/CBA
background, also with no sign of lethality. The Olig1 null of
Lu et al. [1] was made using J1 ES cells (129) and crossed
onto C57 for analysis. The background of our Olig(-/-),
Olig2(Tg) line is mixed C57/CBA and these mice also dis-
play a mild phenotype. The line displaying the contradict-
ory lethal phenotype made by Xin et al. [6] was a
modification of Lu et al.’s [1] line, maintained in a mixed
129/C57 background. Altogether, there is no compellingreason to think that genetic background underlies the dif-
fering severity of Olig1 disruption in different lines.
Another possible reason for the divergent phenotypes
reported by Lu et al. [1] and Xin et al. [6] might lie in
the way in which their mouse lines were generated. Xin
et al. [6] made their line by crossing the mice made pre-
viously by Lu et al. [1] with a line that expresses FLP re-
combinase ubiquitously, in order to effect germ line
excision of the frt-flanked Pgk-Neo cassette. Given that
Olig1 and Olig2 lie close to each other on the chromo-
some (~40 kb apart) and share significant sequence
homologies [24], it is conceivable that an unintended re-
combination event might have taken place, altering the
Olig locus in some way that affects Olig2 expression or
structure in addition to disrupting Olig1.
Arnett et al. [7] previously showed that the Olig1 null line
of Lu et al. [1] inefficiently remyelinates demyelinated le-
sions produced either by focal injection of lysolecithin or by
systemic administration of cuprizone, despite the nearly
normal developmental time course of myelination of these
mice [7]. This implied that Olig2 and Olig1 have comple-
mentary roles in myelin development and repair, respect-
ively. We have no reason to question this conclusion and
have not tested the remyelination abilities of our new Olig1
null mice.
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regulation: 1) epigenetic repression of transcriptional in-
hibitors and 2) direct transcriptional activation of myelin
genes [25]. Transcription factors Olig2 [26], Sox10 [27],
MRF [28] and Zfp191 [21] are critical for OL differenti-
ation and/or myelination. Ascl1 and Nkx2.2 also play
important roles; germ line knockout of either Nkx2.2 or
Ascl1 leads to decreased expression of myelin genes in
neonatal mice, suggesting that both genes can promote
OL maturation [17,29]. In the present study, we have
confirmed that Olig1 deletion delays myelin gene expres-
sion. In addition, our previous work has shown that
Olig1 can synergize with Sox10 to activate Mbp gene
transcription [30]. Taken together, we believe that OL
development is controlled by indispensible core factors
(such as Olig2, Sox10, MRF, Zpf191) in conjunction with
other factors (such as Olig1, Ascl1 and Nkx2.2) that are
not crucial but serve to adjust the timing of OL
differentiation.
Conclusions
Using two newly-generated Olig1 null lines we show that
loss of Olig1 causes a transient delay in OL development
and myelination. Our data confirm the original descrip-
tion of a mild phenotypic effect of Olig1 loss [1], but
run counter to the subsequent report of a complete
myelination block [6]. We have shown that the mild
phenotype is unlikely to result from compensatory up-
regulation of Olig2, as suggested [6]. We conclude that
Olig1 is non-essential for OL development.Additional files
Additional file 1: Figure S1. No NICD expression in Olig1(+/−) or Olig1
(−/−) mice. Proteins from E18.5 spinal cord were subjected to SDS-PAGE,
followed by Western blotting with rabbit anti-Myc antibody.
pPGKcreSV40-transfected MEFs derived from Olig1(+/−) embryos were
used as positive control. The NICD band is indicated by an arrow.
Additional file 2: Figure S2. Our new Olig1 null mice do not express
Olig1 protein. Co-immunolabeling for Olig1 (green) and Sox10 (red) was
performed on sections of E18.5 mouse spinal cords. No Olig1-positive
cells were detected in either Olig1(−/−) (B, B’) or Olig(−/−),Olig2(Tg) spinal
cords (D, D′) in contrast to in Olig1(+/−) (A, A’) or Olig(+/−),Olig2(Tg)
controls (C, C′). Scale bar: 80 μm for A-D and 20 μm for A’-D’.
Additional file 3: Figure S3. No up-regulation of Olig2 expression in
Olig1(−/−) spinal cord. Quantitative PCR using cDNA templates prepared
from E18.5 spinal cord tissue revealed that there was no appreciable
difference in the expression of Olig2 mRNA between Olig1(+/+) and Olig1
(−/−) lines or between Olig(+/−),Olig2(Tg) and Olig(−/−),Olig2(Tg) lines.
Additional file 4: Figure S4. No change in OL numbers in Olig1 null
forebrain at P7. In the developing forebrain, OL differentiation starts in
the first postnatal week. At P7, coronal sections showed that the
numbers of Mbp- and Plp-expressing cells in Olig1 null forebrain (B,F and
D,H respectively) were similar to those in controls (A,E and C,G
respectively). cc, corpus callosum; ctx, cortex. Scale bar: 80 μm.
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